Nebido
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.nebido.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nebido
Grünenthal GmbH specializes in the development and distribution of Nebido, a long-acting injectable testosterone therapy designed for the treatment of hypogonadism. Their products aim to improve various health aspects such as erectile dysfunction, sexual mood, and muscle mass in affected patients. The company also provides a range of testosterone management tools and resources for both healthcare professionals and patients. Their intended clients include individuals suffering from hypogonadism and healthcare providers seeking effective treatment options.Explore more
Popular SearchesNebidoNebidomSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nebido your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nebido
Check if Nebido has recently received funding, and reach out quickly before it becomes old news!
Click to see if Nebido had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nebido has new funding data
Earning: See what the market has to say on Nebido recently announced quarterly report
Check out if Nebido is spiking on competitors!
Product Launch: Get notified when Nebido launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Nebido, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Nebido as Masked Content
Find more new buyers
Compare Similar Companies to Nebido
Compare insights from companies similar to Nebido, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nebido
$5.8M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Nebido is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nebido is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nebido.
Nebido Tech Stack
A closer look at the technologies used by Nebido
Nebido News & Media
Grünenthal acquires testosterone treatment Nebido™ from Bayer
Grünenthal acquires NebidoTM from Bayer AG for up to € 500 million. The product is expected to add about € 100 million to Grünenthal's EBITDA in 2023. NebidoTM is the gold standard for the treatment of male hypogonadism associated with testosterone deficiency. It is available to patients...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nebido
Sign Up For FreeTo access detailed company insights
Grünenthal GmbH specializes in the development and distribution of Nebido, a long-acting injectable testosterone therapy designed for the treatment of hypogonadism. Their products aim to improve various health aspects such as erectile dysfunction, sexual mood, and muscle mass in affected patients. The company also provides a range of testosterone m... Read More
